Product NDC: | 0173-0383 |
Proprietary Name: | ZANTAC |
Non Proprietary Name: | ranitidine hydrochloride |
Active Ingredient(s): | 15 mg/mL & nbsp; ranitidine hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | SYRUP |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0383 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019675 |
Marketing Category: | NDA |
Start Marketing Date: | 19891001 |
Package NDC: | 0173-0383-54 |
Package Description: | 473 mL in 1 BOTTLE (0173-0383-54) |
NDC Code | 0173-0383-54 |
Proprietary Name | ZANTAC |
Package Description | 473 mL in 1 BOTTLE (0173-0383-54) |
Product NDC | 0173-0383 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ranitidine hydrochloride |
Dosage Form Name | SYRUP |
Route Name | ORAL |
Start Marketing Date | 19891001 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | RANITIDINE HYDROCHLORIDE |
Strength Number | 15 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |